MX2008014279A - Derivados de 17-oximacbecina y su uso en el tratamiento de cancer y/o malignidades de celula b. - Google Patents
Derivados de 17-oximacbecina y su uso en el tratamiento de cancer y/o malignidades de celula b.Info
- Publication number
- MX2008014279A MX2008014279A MX2008014279A MX2008014279A MX2008014279A MX 2008014279 A MX2008014279 A MX 2008014279A MX 2008014279 A MX2008014279 A MX 2008014279A MX 2008014279 A MX2008014279 A MX 2008014279A MX 2008014279 A MX2008014279 A MX 2008014279A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- diseases
- treatment
- cell malignancies
- represent
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 12
- 201000011510 cancer Diseases 0.000 title abstract 7
- 230000036210 malignancy Effects 0.000 title abstract 5
- 238000011282 treatment Methods 0.000 title abstract 5
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 4
- 208000023275 Autoimmune disease Diseases 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 2
- 208000031888 Mycoses Diseases 0.000 abstract 2
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000000428 dust Substances 0.000 abstract 2
- 201000004792 malaria Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 230000004770 neurodegeneration Effects 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0609117.7A GB0609117D0 (en) | 2006-05-09 | 2006-05-09 | Novel compounds |
| PCT/EP2007/054473 WO2007128827A1 (en) | 2006-05-09 | 2007-05-09 | 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008014279A true MX2008014279A (es) | 2008-11-26 |
Family
ID=36637122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008014279A MX2008014279A (es) | 2006-05-09 | 2007-05-09 | Derivados de 17-oximacbecina y su uso en el tratamiento de cancer y/o malignidades de celula b. |
Country Status (11)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0718562A2 (pt) * | 2006-11-09 | 2014-04-08 | Biotica Tech Ltd | Composto, processo para preparar e para gerar análogo de macbecina, análogo de macbecina, composição farmacêutica, uso do análogo de macbecina, e, cepa engenheirada. |
| US9967590B2 (en) | 2008-04-10 | 2018-05-08 | Qualcomm Incorporated | Rate-distortion defined interpolation for video coding based on fixed filter or adaptive filter |
| AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| CN110999828A (zh) * | 2019-12-19 | 2020-04-14 | 上海海洋大学 | 改变鱼类体色分布模式的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5360694A (en) * | 1992-10-14 | 1994-05-09 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies |
| JPH11504924A (ja) * | 1995-05-02 | 1999-05-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ベンゾキノン類アンサマイシンによる熱耐性の誘導 |
-
2006
- 2006-05-09 GB GBGB0609117.7A patent/GB0609117D0/en not_active Ceased
-
2007
- 2007-05-09 BR BRPI0711092-8A patent/BRPI0711092A2/pt not_active IP Right Cessation
- 2007-05-09 CN CNA2007800165888A patent/CN101437802A/zh active Pending
- 2007-05-09 JP JP2009508382A patent/JP2009536934A/ja not_active Abandoned
- 2007-05-09 WO PCT/EP2007/054473 patent/WO2007128827A1/en not_active Ceased
- 2007-05-09 US US12/296,537 patent/US20100068203A1/en not_active Abandoned
- 2007-05-09 MX MX2008014279A patent/MX2008014279A/es unknown
- 2007-05-09 AU AU2007247119A patent/AU2007247119A1/en not_active Abandoned
- 2007-05-09 CA CA002651557A patent/CA2651557A1/en not_active Abandoned
- 2007-05-09 KR KR1020087027546A patent/KR20090005377A/ko not_active Withdrawn
- 2007-05-09 EP EP07728925A patent/EP1940798A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB0609117D0 (en) | 2006-06-21 |
| JP2009536934A (ja) | 2009-10-22 |
| WO2007128827A1 (en) | 2007-11-15 |
| US20100068203A1 (en) | 2010-03-18 |
| CA2651557A1 (en) | 2007-11-15 |
| EP1940798A1 (en) | 2008-07-09 |
| CN101437802A (zh) | 2009-05-20 |
| WO2007128827A8 (en) | 2008-01-03 |
| BRPI0711092A2 (pt) | 2011-08-23 |
| AU2007247119A1 (en) | 2007-11-15 |
| KR20090005377A (ko) | 2009-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60329001D1 (en) | 8-hydroxychinolinderivate | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| SI1585739T1 (sl) | Substituirani arilciklopropilacetamidi kot aktivatorji glukokinaze | |
| EP4442695A3 (en) | 19-homo, 3.alpha.-hydroxy-steroid-20-one compounds for treating cns disorders | |
| GEP20115199B (en) | Phosphatidylinositol 3-kinase inhibitors and their use | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| IL181834A0 (en) | Cutting head and adaptor | |
| MX2010004435A (es) | Compuestos espiro y uso farmaceutico de los mismos. | |
| WO2005051946A3 (en) | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity | |
| SI1696905T1 (sl) | Substituirani 2-aminotetralini za preventivno zdravljenje Parkinsonove bolezni | |
| EP4438042A3 (en) | Methods and compositions for inhibition of dihydroorotate dehydrogenase | |
| MY152271A (en) | Novel compounds that are erk inhibitors | |
| MX2013003019A (es) | Compuestos de azabenzotiazol, composiciones y metodos de uso. | |
| WO2005042516A3 (en) | Ligands of melanocortin receptors and compositions and methods related thereto | |
| MXPA05009668A (es) | Proceso libre de azida para preparar compuestos de 1,2-diamino. | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| MY133527A (en) | Isoquinoline derivatives | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
| JO2937B1 (en) | Tight muscles of the peptide vascular tensioner receptor | |
| DE60114640D1 (en) | Antithrombosemittel | |
| WO2007128827A8 (en) | 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies | |
| MX2007005199A (es) | Indolizinas sustituidas y derivados como agentes del sistema nervioso central. | |
| UA98639C2 (en) | Phosphodiesterase inhibitors |